Cancer Incidence after Initiation of Antimuscarinic Medications for Overactive Bladder in the United Kingdom: Evidence for Protopathic Bias

STUDY OBJECTIVE: To estimate the incidence of 10 common cancers among patients treated with antimuscarinic medications for overactive bladder (AMOABs). DESIGN: Retrospective cohort study. DATA SOURCE: United Kingdom's Clinical Practice Research Datalink. PATIENTS: A total of 119,912 adults with...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacotherapy
Hlavní autoři: Kaye, James A., Margulis, Andrea V., Fortuny, Joan, McQuay, Lisa J., Plana, Estel, Bartsch, Jennifer L., Bui, Christine L., Perez‐Gutthann, Susana, Arana, Alejandro
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2017
Témata:
Original Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5518180/
https://ncbi.nlm.nih.gov/pubmed/28370075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1932
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky